Vapes more effective for smoking cessation than nicotine gum and lozenges: Study
A randomized controlled trial (RCT) evaluated whether vaporized nicotine products (VNPs) are more effective than nicotine replacement therapies (NRT) for smoking cessation among people experiencing social disadvantage. The researchers found that VNPs were more effective than NRT for smoking cessation in a low socioeconomic status (low-SES) population. As this population is disproportionately affected by the harms of smoking, VNPs may have a critical role in promoting smoking abstinence. The study is published in Annals of Internal Medicine.
Researchers from the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney, AU and colleagues conducted a two-group, open-label RCT of 1,045 low-SES participants in New South Wales, AU between March 30, 2021 and December 8, 2022. Eligible participants smoked daily, were aged 18 years and over, were willing to make a quit attempt within two weeks of screening and were receiving a government pension or allowance (indicator of low-SES).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.